Today, routine doping controls largely rely on testing whole blood, serum, and urine
samples. These matrices allow comprehensively covering inorganic as well as low and high …

Athletes often experience lower airway dysfunction, such as asthma and exercise‐induced
bronchoconstriction (EIB), which affects more than half the athletes in some sports, not least …

There has been an immense amount of visibility of doping issues on the international stage
over the past 12 months with the complexity of doping controls reiterated on various …

Inhaled medications are commonplace for administering bronchodilators, anticholinergics,
and corticosteroids. While they have a defined legitimate use, they are also used in sporting …

Salbutamol was included in the prohibited list of the World Anti‐Doping Agency (WADA) in
2004. Although systemic intake is banned, inhalation for asthma is permitted but with …

Abstract The 2023 Prohibited List issued by the World Anti‐Doping Agency (WADA) permits
athletes to inhale the beta2‐agonist vilanterol at a standard dose of 25 μg daily. However …

The adrenergic beta-2 agonists formoterol and salbutamol are used for the treatment of
asthma and COPD but are also misused in sports competitions. Therefore, they are included …

Diagnosing and treating elite and Olympic athletes with exercise-induced
bronchoconstriction has been well established. However, a subset of elite and Olympic …

Introduction Many athletes use short-acting inhaled β2-agonists multiple times weekly
during training sessions to prevent exercise-induced bronchoconstriction, but it is unclear if …

Given the prevalent use of inhaled beta2‐agonists in sports, there is an ongoing debate as
to whether they enhance athletic performance. Over the last decades, inhaled beta2 …